NIAID Site Search

NIAID, in coordination with the HHS Biomedical Advanced Research and Development Authority (BARDA), supported preclinical and clinical research to develop several antibody-based therapeutics as anthrax antitoxins. One such product is Anthim, a human monoclonal antibody produced by Elusys Therapeutics, Inc.

Last Reviewed: November 19, 2024

The Laboratory of Host Immunity and Microbiome (LHIM) at NIAID comprehensively examines the factors controlling immunity and inflammation.

Last Reviewed: February 18, 2025

NIAID studies Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) syndrome, a rare genetic disease of the immune system.

Last Reviewed: April 15, 2019

The initiative supports early discovery of novel exploratory vaccine strategies to prevent HIV infection, as well as worthy basic vaccine discovery research that has not yet been fully exploited.

Published: May 17, 2023

The purpose of this study is to evaluate whether Mozobil is safe and effective to treat neutropenia (low white blood cell count) in patients with WHIMS and to determine an appropriate treatment dose of Mozobil, within currently approved dosage levels.

The purpose of this study is to evaluate the clinical and virologic response to escalating doses of 2 different ZIKV strains administered subcutaneously in healthy, ZIKV and DENV-naïve, male and non-pregnant, female adult volunteers to identify the most suitable ZIKV strain and dose for use in a ZIKV CHIM.

Nico Contreras, Ph.D., of University of Arizona, F31 sample application

Last Reviewed: March 31, 2025

Peter Rebeiro, Ph.D., of the Vanderbilt University Medical Center K01 sample application

Last Reviewed: March 31, 2025

Peter Rebeiro, Ph.D., of the Vanderbilt University Medical Center K01 summary statement

Last Reviewed: March 31, 2025

Lenette Lu, M.D., Ph.D., of the Massachusetts General Hospital K08 sample application

Last Reviewed: March 31, 2025

By Steve Grugan, Postbac in the Vector Molecular Biology Section, Laboratory of Malaria and Vector Research (LMVR) As part of the NIAID Summer Career Panels series, the NIAID Office of Research Training and Development recently hosted a Postdoc Career Panel where three NIAID postdoctoral fellows shared their experiences and what they have learned while navigating a career in science. Panelists

Published: July 31, 2023

Stephen Lu, Ph.D., is a postdoctoral researcher who recently completed a three-year research project in the Laboratory of Malaria and Vector Research and the Laboratory of Bacteriology through his participation in the Rocky-Beth Fellowship Program. Learn how this unique collaborative experience prepared him for the next stage of his career.

Published: February 6, 2024

Information about Father of the NIH, Dr. Kinyoun, and his role in fighting the plague in San Francisco.

Last Reviewed: August 28, 2012

I connected with the Vaccine Research Center (VRC) to promote HIV vaccine research. Ultimately, I want to do all I can to raise awareness in the community about HIV/AIDS and help those infected with the virus get the support they need. Together, we can stop the spread of this devastating disease.

Last Reviewed: May 9, 2018

Through scientific research, we gain the ability to prevent or cure disease. I am proud of my part in helping to create these potentially life-saving vaccines. I am grateful that I am able to provide a snug, safe little world for my son, and when he learns of these diseases, I will tell him how his mommy took action to stop them.

Last Reviewed: May 9, 2018

Medicinal chemistry for tuberculosis drug discovery Design and synthesis of chemical probes for the study of Mycobacterium tuberculosis Synthetic approaches for the study of mechanism of action

Last Reviewed: December 21, 2023

In 1917 the “Kinyoun portable bed disinfectors" were being used for sterilization in newly built Army hospitals, named after NIH's Dr. Kinyoun.

Last Reviewed: August 28, 2012

Background information about the childhood experiences of Dr. Joseph Kinyoun, Father of the NIH.

Last Reviewed: August 28, 2012

Immunology Interest Group (IIG) Newsletter November 2024

Last Reviewed: December 4, 2024

Kinyoun has long seemed an indistinct and mysterious character in American biomedical science. Was he a seminal figure or merely a man in the right place at the right time whose role might just as well have been filled by another? Was he a visionary who saw and brought about the future of biomedical science, or an ordinary man of average skills? Would the NIH exist today without him, and if so, in

Last Reviewed: August 28, 2012

This photo story and short video show what it is like to participate in an NIAID clinical research study.

Last Reviewed: January 25, 2024

Liu Application

Last Reviewed: November 5, 2024

Since neither the MHS nor any other federal agency had a bacteriology laboratory capable of studying human diseases, it is unclear what motivated Kinyoun’s next career move, to join the MHS. It is conceivable that his last-minute New York retraining on the specific subject of cholera, his MHS appointment, and his subsequent MHS assignment had somehow been prearranged. In 1885–1886, MHS Surgeon

Last Reviewed: August 28, 2012

An overview of Dr. Kinyoun's experiences after the Marine-Hospital Service (MHS) before his work towards establishing the NIH.

Last Reviewed: August 28, 2012

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024